SUBCUTANEOUS MIDAZOLAM, DIAMORPHINE AND HYOSCINE INFUSION IN PALLIATIVE CARE OF A CHILD WITH NEURODEGENERATIVE DISEASE

被引：7
|
作者：
GRIMSHAW, D
HOLROYD, E
ANTHONY, D
HALL, DMB
机构：
[1] SHEFFIELD CHILDRENS HOSP,SHEFFIELD S10 2TH,S YORKSHIRE,ENGLAND
[2] TADWORTH COURT HOSP,TADWORTH,ENGLAND
[3] UNIV SHEFFIELD,SHEFFIELD,S YORKSHIRE,ENGLAND
来源：
CHILD CARE HEALTH AND DEVELOPMENT | 1995年 / 21卷 / 06期
关键词：
PALLIATIVE CARE; NEURODEGENERATIVE DISEASE; MIDAZOLAM;
D O I：
10.1111/j.1365-2214.1995.tb00767.x
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
We report on the use of a subcutaneous infusion of diamorphine, hyoscine and midazolam in the terminal care of a child with a neurodegenerative disease, The technique was safe and effective, and provided good symptom relief including control of previously intractable seizures.
引用
收藏
页码：377 / 381
页数：5
相关论文
共 36 条
  • [31] Phase III randomised double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care
    Agar, Meera
    Lawlor, Peter
    Quinn, Steve
    Caplan, Gideon
    Draper, Brian
    Rowett, Debra
    Devilee, Linda
    Fazekas, Belinda
    Sanderson, Christine
    McCaffery, Nicola
    Hardy, Janet
    Le, Brian
    Eckermann, Simon
    Hill, Mark
    Currow, David
    AUSTRALASIAN JOURNAL ON AGEING, 2015, 34 : 33 - 33
  • [32] Phase III randomized double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care
    Agar, M.
    Lawlor, P.
    Quinn, S.
    Caplan, G.
    Draper, B.
    Rowett, D.
    Devilee, L.
    Fazekas, B.
    Sanderson, C.
    McCaffrey, N.
    Hardy, J.
    Le, B.
    Eckermann, S.
    Hill, M.
    Currow, D.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S99 - S99
  • [33] How Palliative Care changed a Child's Life with a Very Rare Disease: A Case with Cerebrocostomandibular Syndrome
    Zaidi, Adil H.
    Caylan, Mustafa S.
    Reynoso, Clarissa
    Brinez, Pilar
    Moyer, Alvin
    PEDIATRICS, 2018, 142
  • [34] Terminal Care in Parkinson's Disease: Real-Life Use of Continuous Subcutaneous Apomorphine Infusion to Improve Patient Comfort
    Bereau, Matthieu
    Giffard, Mathilde
    Clairet, Anne-Laure
    Degenne, Guillaume
    Tatu, Laurent
    Richfield, Edward
    Magnin, Eloi
    Verin, Marc
    Auffret, Manon
    JOURNAL OF PARKINSONS DISEASE, 2024, 14 (01) : 209 - 219
  • [35] Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study)
    Lee, Wei
    Sheehan, Caitlin
    Chye, Richard
    Chang, Sungwon
    Loo, Colleen
    Draper, Brian
    Agar, Meera
    Currow, David C.
    BMJ OPEN, 2021, 11 (06):
  • [36] Comparing cost of intravenous infusion and subcutaneous biologics in COVID-19 pandemic care pathways for rheumatoid arthritis and inflammatory bowel disease: A brief UK stakeholder survey
    Heald, Adrian
    Bramham-Jones, Steven
    Davies, Mark
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (09)
1234